TP53 and ovarian cancer: On the other hand, ALDH5A1’s transcription and expression have been suggested to be associated with better overall survival in serous ovarian cancer patients expressing mutated TP53, but not in those expressing wild-type TP53, indicating its crucial role in ovarian cancer progression [170].